CPHI Europe: Gummies as a drug delivery system could improve compliance
Pharmaceutical Technology
OCTOBER 10, 2024
At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing challenges.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Pharmaceutical Technology
OCTOBER 10, 2024
At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing challenges.
Bio Pharma Dive
FEBRUARY 6, 2024
The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JULY 23, 2024
FDA recently released a much-anticipated draft guidance to address these frequent questions: Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products. Drug delivery includes successful product preparation and the initiation, progression, and completion of dose delivery.
XTalks
JANUARY 29, 2025
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drug delivery and drug-device combination product assembly in Rockford, Illinois.
Camargo
NOVEMBER 24, 2020
Interest in the pulmonary route has also grown in recent years because delivering the drugs through the lungs allows direct systemic delivery and bypasses the first pass metabolism. Why is pulmonary drug delivery a complex challenge? How can we accomplish drug delivery to the lungs in nonclinical studies?
Fierce Pharma
SEPTEMBER 24, 2024
Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both sides of the Atlantic. | Altogether, PCI’s manufacturing projects represent an investment of more than $365 million.
Pharmaceutical Technology
OCTOBER 26, 2022
Nano-based delivery systems are on the rise, as they enable manufacturers to deliver therapeutic agents to specific targeted tissue in a more controlled manner. Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 Billion in 2021 and is expected to reach USD 102.4 Billion in 2030.
Pharmaceutical Technology
FEBRUARY 3, 2023
While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry. Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.
BioPharma Reporter
JUNE 10, 2024
CordenPharma, a global CDMO manufacturing complex drug substances and lipid nanoparticles (LNPs), has signed a partnership agreement with Certest, a Spanish company specializing in drug delivery and API synthesis.
Roots Analysis
FEBRUARY 26, 2023
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
Roots Analysis
MARCH 1, 2022
Stakeholders Involved in intranasal therapeutics and drug delivery domain. Most of the drugs (55%) are small molecules. Millions of dollars are being invested in funding the initiatives of various players engaged in the intranasal therapeutics and drug delivery domain. Roots Analysis Report. Web: [link].
pharmaphorum
AUGUST 5, 2020
Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Ophthalmic Drug Delivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Those who register by the 30 th September will save £100 with the early bird discount: [link].
Outsourcing Pharma
JULY 23, 2024
Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.
Outsourcing Pharma
JANUARY 16, 2024
and Argonaut Manufacturing Services Inc., has been formed so biopharma clients can receive end-to-end drug substance and drug product manufacturing solutions. An alliance between KBI Biopharma Inc.,
Pharmacy Checkers
NOVEMBER 6, 2020
The more we know about where our meds are made (mostly not here) the less successful drug industry lobbying will be against lower-cost, imported medicines. In some cases, it’s as simple as a drug sold at a U.S. Walgreens is made in a manufacturing facility in one foreign country. Three countries have a hand in making it.
BioTech 365
NOVEMBER 13, 2020
Global Autoimmune Disorder Drug Delivery Devices Market 2019-2020 & 2030: Focus on Product Type, Indication, Manufacturing Type, Country Data and Competitive Landscape – ResearchAndMarkets.com Global Autoimmune Disorder Drug Delivery Devices Market 2019-2020 & 2030: Focus on Product Type, Indication, Manufacturing … Continue reading (..)
BioTech 365
JULY 28, 2021
Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable Drug Delivery Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities … Continue reading →
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. To boost the profitability of the drug at a later stage in its lifecycle, manufacturers may then consider changing the presentation to prefilled syringes. Lowering extractables levels .
Outsourcing Pharma
JULY 27, 2023
Pfizerâs North Carolina facility was struck by a tornado that caused severe damage to the location and the surrounding area.
Drug Discovery Today
JULY 4, 2023
London, UK, 28 June 2023 / Sciad Newswire / Hosting leading industry experts from across Europe, Connect in Pharma 2023 revealed future trends in pharma and AI, sustainability, and preventative medicine during a two-day meeting in Geneva on 14 & 15 June.
Pharmaceutical Technology
FEBRUARY 27, 2023
Antares Pharma overview Antares Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company employs drug delivery systems to advance drug compounds and drug delivery methods.
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Pharmaceutical Technology
NOVEMBER 7, 2022
SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. Currently, SHL Medical has four locations, in Switzerland, Taiwan, Sweden, and the US, with Taiwan being the main manufacturing location.
Roots Analysis
FEBRUARY 24, 2022
The overall manufacturing of oligonucleotides involves the following steps. Owing to the incessant demand for oligonucleotide-based products, several small to mid-sized companies and certain pharma giants, have begun outsourcing their manufacturing operations to contract service providers. Accelerating Oligonucleotide Demand.
XTalks
MARCH 21, 2025
The rankings are based on each companys ability to tackle critical challenges from drug delivery and diagnostics to personalized therapies using cutting-edge science. At the same time, the company has plans to expand US manufacturing investments to meet rising demand across its growing pipeline, creating around 13,000 jobs.
Outsourcing Pharma
MARCH 16, 2023
The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.
Roots Analysis
FEBRUARY 18, 2022
The current landscape consists of more than 95 players that claim to offer oligonucleotide contract manufacturing services for research, diagnostic and therapeutic applications. It is worth highlighting that major share of the global oligonucleotide manufacturing capacity is installed in North America, primarily in the US. Web: [link].
Outsourcing Pharma
JANUARY 15, 2024
SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging.
XTalks
JANUARY 22, 2025
XTALKS WEBINAR: Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms Live and On-Demand: Thursday, February 27, 2025, at 1pm EST (10am PST) Register for this free webinar to learn critical considerations for improving global vaccine and healthcare delivery and outcomes.
Outsourcing Pharma
JUNE 18, 2024
Cellibre, a pioneer in sustainable biochemical manufacturing, has received a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).
XTalks
MAY 30, 2023
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.
BioPharma Reporter
MARCH 9, 2023
Evonik has opened a new GMP facility to manufacture lipids for advanced pharmaceutical drug delivery applications, which is situated at the companyâs site in Hanau, Germany.
pharmaphorum
OCTOBER 18, 2022
The agreement will see Biocorp’s Injay device incorporated in UltraSafePlus prefilled syringes, giving them digital connectivity that can be used to gather information such as injection completed, time and date, type of drug, batch number and expiration date – al coded by the manufacturer when the syringe is assembled.
Pharmaceutical Technology
SEPTEMBER 15, 2022
Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant.
Outsourcing Pharma
MAY 7, 2024
PCI Pharma Services, a global leader in contract development and manufacturing, has embarked on the installation of crucial equipment for its latest sterile fill-finish facility at its Bedford, NH campus in Philadelphia.
Roots Analysis
MARCH 16, 2022
In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Want additional details on the pipeline?
XTalks
SEPTEMBER 23, 2020
The pen needle is being marketed by HTL-STREFA , a subsidiary of MTD Medical Technology and Devices SA , which is a world-leading Swiss medical technology/medical device group that develops, manufactures and sells safety lancets, personal lancets and pen needles for insulin injection.
BioPharma Reporter
MAY 4, 2022
CPhI North America 2022 host city Philadelphia is set to become one of the worldâs biggest cell and gene therapy manufacturing hubs. But itâs just one of many centers of innovation that are helping drive the US pharma and biopharma industry.
STAT News
NOVEMBER 3, 2022
The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Lilly announced earlier this year that the creation of its proposed manufacturing campus would create 300 permanent jobs once operational as well as 500 jobs during the construction phase.
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
XTalks
MAY 18, 2023
” XTALKS WEBINAR: Drug Delivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about the differences and similarities between the US and EU regulatory frameworks for co-packaged combination products.
Delveinsight
MARCH 2, 2021
HitGen & UPPTHERA Collaborate for Drug Delivery Research. HitGen has entered into a collaboration for drug discovery research with UPPTHERA to identify small molecule Hits against previous known-to-be undruggable targets and novel E3 ligase.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content